Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study

Acta Diabetol. 2021 Apr;58(4):431-436. doi: 10.1007/s00592-020-01637-y. Epub 2020 Nov 21.

Abstract

Aims/hypothesis: The strict rules applied in Italy during the recent COVID-19 pandemic, with the prohibition to attend any regular outdoor activity, are likely to influence the degree of metabolic control in patients with type 2 diabetes. We explored such putative effect immediately after the resolution of lockdown rules, in the absence of any variation of pharmacologic treatment.

Methods: One-hundred and fourteen patients with adequate metabolic control took part in this single-centre, prospective, observational study. The metabolic profile tested 1 week after the end of the lockdown was compared with the last value and the mean of the last three determinations performed before the pandemic emergency (from 6 months to 2 years before).

Results: After 8 weeks of lockdown, an increase of HbA1c > 0.3% (mean +0.7%) was observed in 26% of the participants; these were also characterized by a persistent elevation in serum triglycerides able to predict the worsening of glucose control.

Conclusions: Lockdown determined a relevant short-term metabolic worsening in approximately one-fourth of previously well-controlled type 2 diabetic individuals; pre-lockdown triglycerides were the only parameter able to predict such derangement of glucose control.

Keywords: COVID-19 lockdown; Metabolic control; Physical inactivity; Type 2 diabetes.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Blood Glucose / analysis*
  • COVID-19 / epidemiology*
  • Diabetes Mellitus, Type 2 / blood*
  • Female
  • Glycated Hemoglobin / analysis*
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Quarantine*
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Triglycerides
  • hemoglobin A1c protein, human